Manufacturer
Amgen
Pharmaceutical manufacturer based in United States
United States
- Products listed
- 72
- Molecules
- 26
- Therapy areas
- 9
Amgen is a pharmaceutical manufacturer based in United States. MedsAcross lists 72 of its products across 26 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Country
- United States
- Indian manufacturer
- No
- Also listed as
- Amgen Inc, Amgen USA Inc., Amgen, Inc
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Amgen products through licensed channels, with the documents your regulator needs.
Haematology
20 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Aranesp 10 mcg/0.4 mL injectionIntravenous, subcutaneous Cold chain | Darbepoetin alfa | US FDA | Available on request |
| Aranesp 100 mcg/0.5 mL injectionIntravenous, subcutaneous Cold chain | Darbepoetin alfa | US FDA | Available on request |
| Aranesp 100 mcg/1 mL injectionIntravenous, subcutaneous Cold chain | Darbepoetin alfa | US FDA | Available on request |
| Aranesp 150 mcg/0.3 mL injectionIntravenous, subcutaneous Cold chain | Darbepoetin alfa | US FDA | Available on request |
| Aranesp 200 mcg/0.4 mL injectionIntravenous, subcutaneous Cold chain | Darbepoetin alfa | US FDA | Available on request |
| Aranesp 200 mcg/1 mL injectionIntravenous, subcutaneous Cold chain | Darbepoetin alfa | US FDA | Available on request |
| Aranesp 25 mcg/0.42 mL injectionIntravenous, subcutaneous Cold chain | Darbepoetin alfa | US FDA | Available on request |
| Aranesp 25 mcg/1 mL injectionIntravenous, subcutaneous Cold chain | Darbepoetin alfa | US FDA | Available on request |
| Aranesp 300 mcg/0.6 mL injectionIntravenous, subcutaneous Cold chain | Darbepoetin alfa | US FDA | Available on request |
| Aranesp 40 mcg/0.4 mL injectionIntravenous, subcutaneous Cold chain | Darbepoetin alfa | US FDA | Available on request |
| Aranesp 40 mcg/1 mL injectionIntravenous, subcutaneous Cold chain | Darbepoetin alfa | US FDA | Available on request |
| Aranesp 500 mcg/1 mL injectionIntravenous, subcutaneous Cold chain | Darbepoetin alfa | US FDA | Available on request |
| Aranesp 60 mcg/0.3 mL injectionIntravenous, subcutaneous Cold chain | Darbepoetin alfa | US FDA | Available on request |
| Aranesp 60 mcg/1 mL injectionIntravenous, subcutaneous Cold chain | Darbepoetin alfa | US FDA | Available on request |
| Epogen 10000 IU/mL injectionIntravenous, subcutaneous Cold chain | Epoetin | US FDA | Available on request |
| Epogen 2000 IU/mL injectionIntravenous, subcutaneous Cold chain | Epoetin | US FDA | Available on request |
| Epogen 20000 IU/mL injectionIntravenous, subcutaneous Cold chain | Epoetin | US FDA | Available on request |
| Epogen 3000 IU/mL injectionIntravenous, subcutaneous Cold chain | Epoetin | US FDA | Available on request |
| Epogen 4000 IU/mL injectionIntravenous, subcutaneous Cold chain | Epoetin | US FDA | Available on request |
| Nplate 125 mcg/0.25 mL powder for injectionSubcutaneous Cold chain | Romiplostim | US FDA | Available on request |
Oncology
16 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Blincyto kit Cold chain | Blinatumomab | US FDA | Available on request |
| Imdelltra (AMG757) kit Cold chain | Tarlatamab | US FDA | Available on request |
| Imlygic 1000000 PFU/mL injectable suspensionIntralesional Cold chain | Talimogene laherparepvec | US FDA | Available on request |
| Imlygic 100000000 PFU/mL injectable suspensionIntralesional Cold chain | Talimogene laherparepvec | US FDA | Available on request |
| Kanjinti 150 mg/7.15 mL powder for injectionIntravenous Cold chain | Trastuzumab | US FDA | Available on request |
| Kanjinti 420 mg/20 mL powder for injectionIntravenous Cold chain | Trastuzumab | US FDA | Available on request |
| Lumakras 120 mg tabletOral | Sotorasib | US FDA | Available on request |
| Lumakras 240 mg tabletOral | Sotorasib | US FDA | Available on request |
| Lumakras 320 mg tabletOral | Sotorasib | US FDA | Available on request |
| Mvasi 100 mg/4 mL injectionIntravenous Cold chain | Bevacizumab | US FDA | Available on request |
| Mvasi 400 mg/16 mL injectionIntravenous Cold chain | Bevacizumab | US FDA | Available on request |
| Pavblu 2 mg/0.05 mL injectionIntravitreal | Aflibercept | US FDA | Available on request |
| Riabni 100 mg/10 mL injectionIntravenous Cold chain | Rituximab | US FDA | Available on request |
| Riabni 500 mg/50 mL injectionIntravenous Cold chain | Rituximab | US FDA | Available on request |
| Vectibix 100 mg/5 mL injectionIntravenous Cold chain | Panitumumab | US FDA | Available on request |
| Vectibix 400 mg/20 mL injectionIntravenous Cold chain | Panitumumab | US FDA | Available on request |
Immunology and transplant
13 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Amjevita 10 mg/0.2 mL injectionSubcutaneous Cold chain | Adalimumab | US FDA | Available on request |
| Amjevita 20 mg/0.2 mL injectionSubcutaneous Cold chain | Adalimumab | US FDA | Available on request |
| Amjevita 20 mg/0.4 mL injectionSubcutaneous Cold chain | Adalimumab | US FDA | Available on request |
| Amjevita 40 mg/0.4 mL injectionSubcutaneous Cold chain | Adalimumab | US FDA | Available on request |
| Amjevita 40 mg/0.8 mL injectionSubcutaneous Cold chain | Adalimumab | US FDA | Available on request |
| Amjevita 80 mg/0.8 mL injectionSubcutaneous Cold chain | Adalimumab | US FDA | Available on request |
| Avsola 100 mg/10 mL powder for injectionIntravenous Cold chain | Infliximab | US FDA | Available on request |
| Bkemv 300 mg/30 mL injectionIntravenous Cold chain | Eculizumab | US FDA | Available on request |
| Otezla kit | Apremilast | US FDA | Available on request |
| Otezla kit | Apremilast | US FDA | Available on request |
| Otezla 20 mg tabletOral | Apremilast | US FDA | Available on request |
| Otezla 30 mg tabletOral | Apremilast | US FDA | Available on request |
| Otezla 75 mg tabletOral | Apremilast | US FDA | Available on request |
Immune stimulants
7 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Neulasta kit Cold chain | Pegfilgrastim | US FDA | Available on request |
| Neulasta 4 mg/0.4 mL injectionSubcutaneous Cold chain | Pegfilgrastim | US FDA | Available on request |
| Neulasta 6 mg/0.6 mL injectionSubcutaneous Cold chain | Pegfilgrastim | US FDA | Available on request |
| Neupogen 300 mcg/0.5 mL injectionIntravenous, subcutaneous Cold chain | Filgrastim | US FDA | Available on request |
| Neupogen 300 mcg/1 mL injectionIntravenous, subcutaneous Cold chain | Filgrastim | US FDA | Available on request |
| Neupogen 480 mcg/0.8 mL injectionIntravenous, subcutaneous Cold chain | Filgrastim | US FDA | Available on request |
| Neupogen 480 mcg/1.6 mL injectionIntravenous, subcutaneous Cold chain | Filgrastim | US FDA | Available on request |
Endocrinology
6 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Parsabiv 10 mg/2 mL injectionIntravenous Cold chain | Etelcalcetide | US FDA | Available on request |
| Parsabiv 2.5 mg/0.5 mL injectionIntravenous Cold chain | Etelcalcetide | US FDA | Available on request |
| Parsabiv 5 mg/1 mL injectionIntravenous Cold chain | Etelcalcetide | US FDA | Available on request |
| Sensipar 30 mg tabletOral | Cinacalcet | US FDA | Available on request |
| Sensipar 60 mg tabletOral | Cinacalcet | US FDA | Available on request |
| Sensipar 90 mg tabletOral | Cinacalcet | US FDA | Available on request |
Cardiology
4 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Corlanor 5 mg tabletOral | Ivabradine | US FDA | Available on request |
| Corlanor 5 mg/5 mL oral solutionOral | Ivabradine | US FDA | Available on request |
| Corlanor 7.5 mg tabletOral | Ivabradine | US FDA | Available on request |
| Repatha 140 mg/1 mL injectionSubcutaneous Cold chain | Evolocumab | US FDA | Available on request |
Bone health
3 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Evenity 105 mg/1.17 mL injectionSubcutaneous Cold chain | Romosozumab | US FDA | Available on request |
| Prolia 60 mg/1 mL injectionSubcutaneous Cold chain | Denosumab | US FDA | Available on request |
| Xgeva 120 mg/1.7 mL injectionSubcutaneous Cold chain | Denosumab | US FDA | Available on request |
Pain and anaesthesia
2 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Aimovig 140 mg/1 mL injectionSubcutaneous Cold chain | Erenumab | US FDA | Available on request |
| Aimovig 70 mg/1 mL injectionSubcutaneous Cold chain | Erenumab | US FDA | Available on request |
Respiratory
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Tezspire 211.105 mg/1.91 mL injectionSubcutaneous Cold chain | Tezepelumab | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Amgen
Send a request for any of these products. We confirm the licensed source, documents and lead time.